Vetter, well-known CMO and experienced aseptic parenteral processor, recently achieved Authorized Economic Operator Full (AEO-F) status from the European Union. Internationally accepted, AEO-F certification affirms that Vetter maintains the highest reliability, solvency and safety standards in international pharmaceutical trade. The AEO-F certificate is currently accepted by the U.S. and Japan, the EU Member States, Switzerland, Norway and China.
According to Vetter, the certification facilitates the import of drugs in third countries and confirms the quality, reliability and performance of its entire supply chain. Equipped with the AEO-F, customs procedures associated with consignments will be simplified and accelerated, “all of which results in shortened transport durations, as well as improved fulfillment of pharmaceutical requirements for transit times,” says the company’s press release. Another advantage, said Vetter, is how it accelerates regulatory proceedings for security reviews and audits.
"With the recognition afforded by the granting of the AEO-F certificate, we can enable our customers not only a fast and smooth international customs clearance, but more importantly, a very high standard of safety,” explained Vetter Supply Chain Management SVP Carsten Press. “The certification is important for Vetter, and at the same time, it is also further evidence of the high service and product quality we offer to our customers.”
